AKAP12 and AKAP5 form higher-order hetero-oligomers
Tóm tắt
The family of A-kinase-anchoring proteins, AKAPs, constitutes a group of molecular scaffolds that act to catalyze dynamic interactions of protein kinase A, protein kinase C, tyrosine kinases, G-protein-coupled receptors and ion channels. AKAP5 (MW ~47 kDa) and AKAP12 (MW ~191 kDa) homo-oligomerize, but whether or not such AKAPs can hetero-oligomerize into supermolecular scaffolds of increased complexity is unknown. Affinity chromatography using immobilized AKAPs as "bait" demonstrates unequivocally that AKAP5 and AKAP12 do form minimally hetero-dimers. Steric-exclusion chromatography of AKAP5 and AKAP12 mixtures revealed the existence of very large, supermolecular complexes containing both AKAPs. Docking of AKAP5 to AKAP12 was increased 4-fold by beta-adrenergic agonist stimulation. Overexpression of AKAP12 was found to potentiate AKAP5-mediated Erk1/2 activation in response to stimulation with beta-adrenergic agonist. AKAP5 and AKAP12 are capable of forming hetero-oligomeric supermolecular complexes that influence AKAP locale and function.
Tài liệu tham khảo
Bregman DB, Bhattacharyya N, Rubin CS: High affinity binding protein for the regulatory subunit of cAMP-dependent protein kinase II-B. Cloning, characterization, and expression of cDNAs for rat brain P150. J Biol Chem 1989, 264:4648–4656.
Gold MG, Lygren B, Dokurno P, Hoshi N, McConnachie G, Tasken K, Carlson CR, Scott JD, Barford D: Molecular basis of AKAP specificity for PKA regulatory subunits. Mol Cell 2006, 24:383–395.
Hoshi N, Langeberg LK, Scott JD: Distinct enzyme combinations in AKAP signalling complexes permit functional diversity. Nat Cell Biol 2005, 7:1066–1073.
Wong W, Scott JD: AKAP signalling complexes: focal points in space and time. Nat Rev Mol Cell Biol 2004, 5:959–970.
Welch EJ, Jones BW, Scott JD: Networking with AKAPs: context-dependent regulation of anchored enzymes. Mol Interv 2010, 10:86–97.
Hoshi N, Langeberg LK, Gould CM, Newton AC, Scott JD: Interaction with AKAP79 modifies the cellular pharmacology of PKC. Mol Cell 2010, 37:541–550.
Shih M, Lin F, Scott JD, Wang HY, Malbon CC: Dynamic complexes of beta2-adrenergic receptors with protein kinases and phosphatases and the role of gravin. J Biol Chem 1999, 274:1588–1595.
Weisenhaus M, Allen ML, Yang L, Lu Y, Nichols CB, Su T, Hell JW, McKnight GS: Mutations in AKAP5 disrupt dendritic signaling complexes and lead to electrophysiological and behavioral phenotypes in mice. PLoS One 2010, 5:e10325.
Tao J, Wang HY, Malbon CC: Src docks to A-kinase anchoring protein gravin, regulating beta2-adrenergic receptor resensitization and recycling. J Biol Chem 2007, 282:6597–6608.
Malbon CC, Tao J, Shumay E, Wang HY: AKAP (A-kinase anchoring protein) domains: beads of structure-function on the necklace of G-protein signalling. Biochem Soc Trans 2004, 32:861–864.
Baillie GS, Houslay MD: Arrestin times for compartmentalised cAMP signalling and phosphodiesterase-4 enzymes. Curr Opin Cell Biol 2005, 17:129–134.
Dodge-Kafka KL, Soughayer J, Pare GC, Carlisle Michel JJ, Langeberg LK, Kapiloff MS, Scott JD: The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature 2005, 437:574–578.
Perry SJ, Baillie GS, Kohout TA, McPhee I, Magiera MM, Ang KL, Miller WE, McLean AJ, Conti M, Houslay MD, et al.: Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins. Science 2002, 298:834–836.
Willoughby D, Wong W, Schaack J, Scott JD, Cooper DM: An anchored PKA and PDE4 complex regulates subplasmalemmal cAMP dynamics. EMBO J 2006, 25:2051–2061.
Lin F, Wang H, Malbon CC: Gravin-mediated formation of signaling complexes in beta 2-adrenergic receptor desensitization and resensitization. J Biol Chem 2000, 275:19025–19034.
Shih M, Malbon CC: Serum and insulin induce a Grb2-dependent shift in agonist affinity of beta-adrenergic receptors. Cell Signal 1998, 10:575–582.
Scott JD, Santana LF: A-kinase anchoring proteins: getting to the heart of the matter. Circulation 2010, 121:1264–1271.
Carnegie GK, Means CK, Scott JD: A-kinase anchoring proteins: from protein complexes to physiology and disease. IUBMB Life 2009, 61:394–406.
Beene DL, Scott JD: A-kinase anchoring proteins take shape. Curr Opin Cell Biol 2007, 19:192–198.
Colledge M, Scott JD: AKAPs: from structure to function. Trends Cell Biol 1999, 9:216–221.
Fan G, Shumay E, Wang H, Malbon CC: The scaffold protein gravin (cAMP-dependent protein kinase-anchoring protein 250) binds the beta 2-adrenergic receptor via the receptor cytoplasmic Arg-329 to Leu-413 domain and provides a mobile scaffold during desensitization. J Biol Chem 2001, 276:24005–24014.
Malbon CC, Tao J, Wang HY: AKAPs (A-kinase anchoring proteins) and molecules that compose their G-protein-coupled receptor signalling complexes. Biochem J 2004, 379:1–9.
Tao J, Malbon CC: G-protein-coupled receptor-associated A-kinase anchoring proteins AKAP5 and AKAP12: differential signaling to MAPK and GPCR recycling. J Mol Signal 2008, 3:19.
Chen MH, Malbon CC: G-protein-coupled receptor-associated A-kinase anchoring proteins AKAP5 and AKAP12: differential trafficking and distribution. Cell Signal 2009, 21:136–142.
Tao J, Wang HY, Malbon CC: AKAR2-AKAP12 fusion protein "biosenses" dynamic phosphorylation and localization of a GPCR-based scaffold. J Mol Signal 2010, 5:3.
Wang HY, Tao J, Shumay E, Malbon CC: G-Protein-coupled receptor-associated A-kinase anchoring proteins: AKAP79 and AKAP250 (gravin). Eur J Cell Biol 2006, 85:643–650.
Tao J, Wang HY, Malbon CC: Protein kinase A regulates AKAP250 (gravin) scaffold binding to the beta2-adrenergic receptor. EMBO J 2003, 22:6419–6429.
Gao S, Wang HY, Malbon CC: AKAP5 and AKAP12 form homo-oligomers. J Mol Signal 2011, 6:3.
Gold MG, Stengel F, Nygren PJ, Weisbrod CR, Bruce JE, Robinson CV, Barford D, Scott JD: Architecture and dynamics of an A-kinase anchoring protein 79 (AKAP79) signaling complex. Proc Natl Acad Sci USA 2011, 108:6426–6431.
Delavier-Klutchko C, Hoebeke J, Strosberg AD: The human carcinoma cell line A431 possesses large numbers of functional beta-adrenergic receptors. FEBS Lett 1984, 169:151–155.
Wang HY, Berrios M, Hadcock JR, Malbon CC: The biology of beta-adrenergic receptors: analysis in human epidermoid carcinoma A431 cells. Int J Biochem 1991, 23:7–20.
Thomas P, Smart TG: HEK293 cell line: a vehicle for the expression of recombinant proteins. J Pharmacol Toxicol Methods 2005, 51:187–200.
Shih M, Malbon CC: Oligodeoxynucleotides antisense to mRNA encoding protein kinase A, protein kinase C, and beta-adrenergic receptor kinase reveal distinctive cell-type-specific roles in agonist-induced desensitization. Proc Natl Acad Sci USA 1994, 91:12193–12197.
Tao J, Shumay E, McLaughlin S, Wang HY, Malbon CC: Regulation of AKAP-membrane interactions by calcium. J Biol Chem 2006, 281:23932–23944.
Marsh JD, Roberts DJ: Adenylate cyclase regulation in intact cultured myocardial cells. Am J Physiol 1987, 252:C47-C54.
Willoughby D, Masada N, Wachten S, Pagano M, Halls ML, Everett KL, Ciruela A, Cooper DM: AKAP79/150 interacts with AC8 and regulates Ca2+-dependent cAMP synthesis in pancreatic and neuronal systems. J Biol Chem 2010, 285:20328–20342.
Prilusky J, Felder CE, Zeev-Ben-Mordehai T, Rydberg EH, Man O, Beckmann JS, Silman I, Sussman JL: FoldIndex: a simple tool to predict whether a given protein sequence is intrinsically unfolded. Bioinformatics 2005, 21:3435–3438.
Shimizu K, Muraoka Y, Hirose S, Tomii K, Noguchi T: Predicting mostly disordered proteins by using structure-unknown protein data. BMC Bioinformatics 2007, 8:78.
Malbon CC, Wang HY: Dishevelled: a mobile scaffold catalyzing development. Curr Top Dev Biol 2006, 72:153–166.
Yokoyama N, Yin D, Malbon CC: Abundance, complexation, and trafficking of Wnt/beta-catenin signaling elements in response to Wnt3a. J Mol Signal 2007, 2:11.